These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 29486369)
1. Discovery and optimization of 2-thio-5-amino substituted benzoquinones as potent anticancer agents. Zhao Y; Lu Y; Li R; He J; Zhang H; Wang X; Ge Z; Li R Eur J Med Chem; 2018 Apr; 149():1-9. PubMed ID: 29486369 [TBL] [Abstract][Full Text] [Related]
2. Discovery of novel heteroarylmethylcarbamodithioates as potent anticancer agents: Synthesis, structure-activity relationship analysis and biological evaluation. Li YB; Yan X; Li RD; Liu P; Sun SQ; Wang X; Cui JR; Zhou DM; Ge ZM; Li RT Eur J Med Chem; 2016 Apr; 112():217-230. PubMed ID: 26900655 [TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, Biological Evaluation, and Antioxidant and Cytotoxic Activity of Heteroatom-Substituted 1,4-Naphtho- and Benzoquinones. Deniz NG; Ibis C; Gokmen Z; Stasevych M; Novikov V; Komarovska-Porokhnyavets O; Ozyurek M; Guclu K; Karakas D; Ulukaya E Chem Pharm Bull (Tokyo); 2015; 63(12):1029-39. PubMed ID: 26633024 [TBL] [Abstract][Full Text] [Related]
4. Discovery of novel 17-phenylethylaminegeldanamycin derivatives as potent Hsp90 inhibitors. Li Z; Jia L; Wang J; Wu X; Shi G; Lu C; Shen Y Chem Biol Drug Des; 2015 Feb; 85(2):181-8. PubMed ID: 24903735 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel 2'-hydroxy group substituted 2-pyridone derivatives as anticancer agents. Lv Z; Zhang Y; Zhang M; Chen H; Sun Z; Geng D; Niu C; Li K Eur J Med Chem; 2013 Sep; 67():447-53. PubMed ID: 23920246 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and in-vitro anticancer activity of 3,5-bis(indolyl)-1,2,4-thiadiazoles. Kumar D; Kumar NM; Chang KH; Gupta R; Shah K Bioorg Med Chem Lett; 2011 Oct; 21(19):5897-900. PubMed ID: 21873049 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives. Hao J; Liu J; Wen X; Sun H Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel 4-phenoxy-6,7-disubstituted quinolines possessing (thio)semicarbazones as c-Met kinase inhibitors. Zhai X; Bao G; Wang L; Cheng M; Zhao M; Zhao S; Zhou H; Gong P Bioorg Med Chem; 2016 Mar; 24(6):1331-45. PubMed ID: 26897090 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and cancer cell cytotoxicity of water-soluble gold(III) substituted tetraarylporphyrin. Sun L; Chen H; Zhang Z; Yang Q; Tong H; Xu A; Wang C J Inorg Biochem; 2012 Mar; 108():47-52. PubMed ID: 22265838 [TBL] [Abstract][Full Text] [Related]
10. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro. Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of human 5-lipoxygenase and anti-neoplastic effects by 2-amino-1,4-benzoquinones. Poeckel D; Niedermeyer TH; Pham HT; Mikolasch A; Mundt S; Lindequist U; Lalk M; Werz O Med Chem; 2006 Nov; 2(6):591-5. PubMed ID: 17105440 [TBL] [Abstract][Full Text] [Related]
12. Chalcone-benzoxaborole hybrids as novel anticancer agents. Zhang J; Yang F; Qiao Z; Zhu M; Zhou H Bioorg Med Chem Lett; 2016 Dec; 26(23):5797-5801. PubMed ID: 28327308 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites. Lee K; Ryu JS; Jin Y; Kim W; Kaur N; Chung SJ; Jeon YJ; Park JT; Bang JS; Lee HS; Kim TY; Lee JJ; Hong YS Org Biomol Chem; 2008 Jan; 6(2):340-8. PubMed ID: 18175003 [TBL] [Abstract][Full Text] [Related]
14. Discovery and optimization of novel dual dithiocarbamates as potent anticancer agents. Li RD; Wang HL; Li YB; Wang ZQ; Wang X; Wang YT; Ge ZM; Li RT Eur J Med Chem; 2015 Mar; 93():381-91. PubMed ID: 25725374 [TBL] [Abstract][Full Text] [Related]
15. Discovery and structure-activity relationship of novel 4-hydroxy-thiazolidine-2-thione derivatives as tumor cell specific pyruvate kinase M2 activators. Li R; Ning X; Zhou S; Lin Z; Wu X; Chen H; Bai X; Wang X; Ge Z; Li R; Yin Y Eur J Med Chem; 2018 Jan; 143():48-65. PubMed ID: 29172082 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and Anticancer Activity of 3-(Substituted Aroyl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole Derivatives. Zhan XP; Lan L; Wang S; Zhao K; Xin YX; Qi Q; Wang YL; Mao ZM Chem Biodivers; 2017 Feb; 14(2):. PubMed ID: 27696660 [TBL] [Abstract][Full Text] [Related]
17. Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused libraries. Tao Y; Hao X; Jing L; Sun L; Cherukupalli S; Liu S; Wu G; Xu S; Zhang X; Shi X; Song Y; Liu X; Zhan P Bioorg Chem; 2021 Oct; 115():105254. PubMed ID: 34426152 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents. Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological activities of sorafenib derivatives as antitumor agents. Yao J; He Z; Chen J; Sun W; Fang H; Xu W Bioorg Med Chem Lett; 2012 Nov; 22(21):6549-53. PubMed ID: 23021967 [TBL] [Abstract][Full Text] [Related]
20. Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer. Krasavin M; Karapetian R; Konstantinov I; Gezentsvey Y; Bukhryakov K; Godovykh E; Soldatkina O; Lavrovsky Y; Sosnov AV; Gakh AA Arch Pharm (Weinheim); 2009 Jul; 342(7):420-7. PubMed ID: 19544302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]